Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data POET TECHNOLOGIES INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
1.86
2.79
3.89
0.21
0.55
0.47
0.04
1.07
Cost of revenue
0.95
1.34
1.48
Gross profit
0.92
1.45
2.41
Research and development
3.17
2.04
2.26
2.08
6.63
8.17
10.7
10.1
11.3
18.1
Selling, general and administrative
11.4
5.89
6.17
6.7
8.14
9.06
9.52
10.8
18.8
25.1
Operating income
-13.7
-7.91
-8.42
-11.4
-18.2
-15.7
Pre-tax income
-13.4
-7.91
-8.42
-11.7
-18.2
-15.7
-21
-20.3
-56.7
-63
Income tax
-0.21
-0.3
-0.3
-0.29
Income from continuing operations
-8.42
-11.4
-18.2
-15.7
Net income
-13.2
-12.8
-16.3
-5.95
-18.2
-15.7
-21
-20.3
-56.7
-63
EPS, basic
-0.06
-0.05
-0.06
-0.02
-0.45
-0.57
-0.51
-0.94
-0.68
EPS, diluted
-0.06
-0.05
-0.06
-0.02
-0.45
-0.57
-0.51
-0.94
-0.68
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
14.4
4.97
2.57
1.43
6.87
14.9
9.23
3.02
37.1
40
Short-term investments
0.59
0
0
6.37
16.7
273
Inventory
1.12
0.52
0.44
Total current assets
17.1
7.95
6.89
20.3
7.49
21.8
9.57
3.17
55.5
314
Property, plant and equipment
9.36
8.28
9.3
3.14
3.19
3.06
5.07
4.62
12.8
12.2
Lease right-of-use assets
0.22
0.52
0.33
0.24
0.48
0.7
1.11
Goodwill
7.68
7.68
7.68
Intangible assets
0.88
0.84
0.8
Total assets
35.5
25.2
25.1
24.1
11.6
27.2
15.4
8.78
69.7
329
Accounts payable
1.62
0.81
3.04
1.73
1.73
1.79
3.36
2.3
5.97
1.64
Short-term debt
-3.09
-3.34
Total current liabilities
1.62
0.81
3.04
4.91
5.39
1.92
3.82
3.54
48.3
144
Lease liabilities
0.13
0.36
0.26
0.13
0.31
0.63
1.03
Total liabilities
3.26
2.13
4.04
5.04
5.82
2.18
3.95
3.85
49
145
Paid-in capital
29.1
32.1
36
38.8
44.4
47
51
55.4
58.7
9.33
Retained earnings
-104
-133
-133
-139
-157
-173
-194
-214
-271
-297
Total equity
32.2
23.1
21.1
19
5.81
25
11.4
4.93
20.7
184
Total liabilities and equity
35.5
25.2
25.1
24.1
11.6
27.2
15.4
8.78
69.7
329
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-13.2
-12.8
-16.3
-5.95
-18.2
-15.7
-21
-20.3
-56.7
-63
Cash from operations
-9.96
-9.16
-9.29
-9.39
-9.44
-11.2
-12.3
-15.4
-23.3
-31.1
Capital expenditures
-1.21
-0.06
-3.47
-0.45
-1.52
-0.77
-3.01
-1.17
-6.78
-2.26
Cash from investing
-2.32
-0.44
-3.54
5.39
13.9
-7.3
3.29
-1.25
-23.7
-259
Debt issued
0.22
Cash from financing
11.8
0.12
10.6
3.14
1.16
26.6
3.44
10.2
81.9
292
Exchange rate effect
0.47
0.08
-0.23
-0.27
-0.21
0.05
-0.11
0.25
-0.82
0.75
Net change in cash
-0.03
-9.4
-2.41
5.44
8.07
-5.71
-6.21
34.1
2.82
Free cash flow
-11.2
-9.22
-12.8
-9.84
-11
-12
-15.3
-16.6
-30.1
-33.3
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $7.77 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Pre-tax margin
-5,858.0%
Pre-tax income / revenue.
Net margin
-5,858.0%
Net income / revenue.
FCF margin
-3,102.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-2,892.0%
Cash from operations / revenue.
Return on assets (ROA)
-31.6%
Net income / average total assets.
R&D / revenue
1,682.0%
Research and development expense / revenue.
SG&A / revenue
2,333.0%
Selling, general and administrative expense / revenue.
Capex / revenue
209.8%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
2,495.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
24.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
371.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
177.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
95.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.19x
Current assets / current liabilities.
Quick ratio
2.18x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.18x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
44.1%
Total liabilities / total assets.
Working capital
$170.7M
Current assets - current liabilities.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.01x
Revenue / average total assets.
Fixed asset turnover
0.09x
Revenue / average property, plant and equipment.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.68
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.68
Net income per basic share, as reported (split-adjusted).
Valuation
Metric
Value
How it is calculated
Market cap
$1.34B
Share price x shares outstanding.
Enterprise value
$1.03B
Market cap + total debt - cash - short-term investments.
P/S
1,251x
Market cap / revenue.
EV/Sales
959x
Enterprise value / revenue.
FCF yield
-2.5%
Free cash flow / market cap.
Earnings yield
-4.7%
Net income / market cap (the inverse of P/E).
What was POET TECHNOLOGIES INC.'s revenue in fiscal 2025?
POET TECHNOLOGIES INC. reported revenue of $1.1M for fiscal 2025, 2,494.6% higher than the year before.
Was POET TECHNOLOGIES INC. profitable in fiscal 2025?
No. It reported a net loss of $63.0M.
How much free cash flow did POET TECHNOLOGIES INC. generate in fiscal 2025?
Cash from operations of $31.1M minus capital expenditures of $2.3M left free cash flow of -$33.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.